Discovery Labs Receives US Patent for Pulmonary Surfactant Formulations


27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


Discovery Laboratories,Inc. (Nasdaq: DSCO) today announced it has received a patent issued by theUnited States Patent and Trademark Office (USPTO) entitled "PulmonarySurfactant Formulations." The claims of the patent (U.S. Patent Number8,337,815) provide coverage for synthetic pulmonary surfactant compositionscomprising a combination of a proprietary synthetic peptide and variouslipids. The patent term expires in December 2028.This patent provides exclusivity for new formulations of KL4 surfactant and isseparate and distinct from the patent portfolios covering SURFAXIN, theCompany's lead KL4 surfactant product, and AEROSURF^®, the Company's lead KL4surfactant development program.

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: News